Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 312.90
-4.10 (-1.29%)
Aug 28, 2026, 4:59 PM CET
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 21.31 billion as of August 28, 2026. Its market cap has decreased by -28.60% in one year.
Market Cap
21.31B
Enterprise Value
7.27B
Revenue
4.64B
Ranking
n/a
PE Ratio
8.12
Stock Price
312.90
ChartMarket Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 21.31B, an increase of 1,416.15%. That is a compound annual growth rate of 18.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 21.31B | -35.12% |
| Dec 30, 2025 | 32.85B | -35.01% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.31T |
| Genmab | 129.37B |
| Coloplast | 103.35B |
| Demant | 60.32B |
| ALK-Abelló | 47.08B |
| H. Lundbeck | 41.38B |
| Ambu A/S | 18.51B |
| Bavarian Nordic | 16.13B |